Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
Unmasking IgAN: From Suspicion to Timely Diagnosis
Jörg Latus, MD
Chee Kay Cheung, MBCHB, MRCP, PHD
Cardiorenal Collaboration: Escape the Treatment Trap
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Advances in IgAN Care From Kidney Week
Sydney Tang, MBBS, MD
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
James Burton, DM, FRCP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, MD
Jonathan Barratt, PhD
Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Raymond Townsend, MD
Michael Weber, MD
Unveiling the Latest Advancements in CKD-Associated Pruritus Care
Stefan H. Jacobson, MD, PhD
Carlos Narváez Mejía, MD
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
Kelly Chenlei Li, MBBS, FRACP
Paul Bennett, RN, MHSM, PhD, FISN
Thilo Krüger, MD, PhD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Can We Do Better in IgAN?
Annette Bruchfeld, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Kieran McCafferty, MD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD